Rivastigmine Actavis

Medicinal product

(Invented) name

Rivastigmine Actavis

Active substance (s)

Rivastigminas

Strength

4,6 mg/24 val.

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti per odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06DA03, Rivastigmine

Marketing authorisation holder

Actavis Group PTC ehf., Islandija

Date of authorisation

2011-06-16

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Rivastigminas	4,6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61796	76152	1076152	maišelis.	N7		Receptinis	EU/1/11/693/017	Netiekiama	-	-	No	-	-
61797	76153	1076153	maišelis.	N30		Receptinis	EU/1/11/693/018	Netiekiama	-	-	No	-	-
61798	76154	1076154	maišelis.	N60		Receptinis	EU/1/11/693/019	Netiekiama	-	-	No	-	-
61799	76155	1076155	maišelis.	N90		Receptinis	EU/1/11/693/020	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2011-06-16	Registruotas